News releases
Showing 11 - 20 of 28 results
November 14, 2024
Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and the related challenge of timely patient access to lifesaving interventions such ... read more
August 15, 2024
These insights enable providers to optimize their care delivery models, improve patient access and experience and plan for enterprise growth in the communities they serve... read more
July 30, 2024
The report points to expanding indications of previously approved medications, such as semaglutide, as partial cause for the projected increase. It also urges providers to prepare for an increased nu... read more
June 26, 2024
The agreement includes access to Vizient’s industry-leading contract portfolio of medical devices, supplies and pharmaceuticals as well as analytics-enabled solutions to drive operational and clinica... read more
June 26, 2024
Sg2, a Vizient, Inc. company, released its 2024 Impact of Change®, projecting continued constraints on patient access to emergency department (ED) and inpatient (IP) care... read more
June 21, 2024
The agreement was effective in the last quarter of 2023 and reflects Vizient’s continued commitment to supporting providers in high-value care... read more
May 15, 2024
While the prevalence of behavioral health conditions was roughly the same in both groups, treatment and emergency department visits among patients in each group varied... read more
March 25, 2024
The agreement includes a suite of Vizient spend management tools and access to operational and clinical analytics... read more
August 29, 2023
The report, which utilizes data from Medicare’s Qualified Entity Program, explores outcomes through the lens of high social need communities, evaluating the cost and quality of care provided to patie... read more
August 23, 2023
A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancer... read more